Figures & data
Table 1 Clinical findings of two groups
Figure 1 Tumor response of patients in the group with transarterial chemoembolization with drug-eluting beads.
Notes: A 48-year-old male with hepatocellular carcinoma and grade 3 arterioportal shunt: contrast-enhanced computed tomography scan showed a hepatic arterial phase hyperattenuation lesion with a maximal diameter of 106.5 mm, the arterial flow was drained into the main portal vein (black arrow) (A), and the portal venous phase showed tumor thrombus (white arrow) (B); a follow-up magnetic resonance scan was performed after 3 months, showing that the maximal diameter of the tumor was increased to 151.8 mm and indicating a tumor response of progression disease, the hepatic arterial phase (C), and the portal venous phase (D).
![Figure 1 Tumor response of patients in the group with transarterial chemoembolization with drug-eluting beads.Notes: A 48-year-old male with hepatocellular carcinoma and grade 3 arterioportal shunt: contrast-enhanced computed tomography scan showed a hepatic arterial phase hyperattenuation lesion with a maximal diameter of 106.5 mm, the arterial flow was drained into the main portal vein (black arrow) (A), and the portal venous phase showed tumor thrombus (white arrow) (B); a follow-up magnetic resonance scan was performed after 3 months, showing that the maximal diameter of the tumor was increased to 151.8 mm and indicating a tumor response of progression disease, the hepatic arterial phase (C), and the portal venous phase (D).](/cms/asset/ff2778f5-e31f-4d08-98dc-fa56cfc8a1cf/dcmr_a_12186248_f0001_b.jpg)
Table 2 Efficacy assessment of two groups
Figure 2 The overall survival of patients in the DEB-TACE group and PVA-TACE group.
Abbreviations: DEB-TACE, transarterial chemoembolization with drug-eluting beads; PVA-TACE, polyvinyl alcohol plus transarterial chemoembolization.
![Figure 2 The overall survival of patients in the DEB-TACE group and PVA-TACE group.Abbreviations: DEB-TACE, transarterial chemoembolization with drug-eluting beads; PVA-TACE, polyvinyl alcohol plus transarterial chemoembolization.](/cms/asset/6c3ca3aa-b4d7-4745-ac07-930c2c80ca8a/dcmr_a_12186248_f0002_b.jpg)
Table 3 Univariate and multivariate analyses of survival in DEB-TACE group
Table 4 Safety assessment of two groups